An 80-year-old woman from the United Kingdom is the first patient to undergo gene therapy to treat age-related macular degeneration — the most common cause of sight loss in the world.
The first US trial using CRISPR to treat disease in people is imminent, a significant step in testing the true power of gene editing in the clinic. In the future, the US government is hoping that therapies for cancer and other diseases using gene editing will reach a lot more…